At Weill Cornell, where Dr. Leonard N. Girardi and his team of cardiac and thoracic surgeons have demonstrated time and time again that by combining their expertise in the OR they can successfully and completely remove the tumor.

Martin B. Leon, MD, Director of the Center for Interventional Vascular Therapy at NewYork-Presbyterian/Columbia University Irving Medical Center, has been awarded the 2019 Lifetime Achievement Award by the American College of Cardiology (ACC) in honor of his contributions to the field of interventional cardiology.

A multicenter clinical trial has found that transcatheter aortic valve replacement (TAVR) performed better than open heart surgery in patients with severe aortic stenosis at low surgical risk.

Renowned cardiothoracic surgeon Stephanie L. Mick, MD, has joined the Department of Cardiothoracic Surgery at NewYork-Presbyterian/ Weill Cornell Medical Center as Director of Robotic and Minimally Invasive Cardiac Surgery.

Dr. Nir Uriel, an internationally recognized leader in heart failure, mechanical circulatory support, and heart transplantation, will oversee heart failure programs at NewYork-Presbyterian’s campuses in Manhattan, Queens, Brooklyn, and Westchester.

Young people with a history of strokes caused by blood clots should be evaluated for a patent foramen ovale (PFO) closure, according to Hooman Kamel, MD, a neurologist with expertise in stroke at NewYork-Presbyterian/Weill Cornell.

A multicenter clinical trial has found that minimally invasive transcatheter mitral valve repair significantly reduced hospitalizations and mortality for heart failure patients with moderate-to-severe or severe functional mitral regurgitation.

Weill Cornell Medicine researchers have shown that hospitals that routinely perform a heart valve replacement procedure that requires open heart surgery are more likely to adopt a newer, less invasive technique.